S-nitrosothiols modulate G protein-coupled receptor signaling in a reversible and highly receptor-specific manner

BMC Cell Biology

Volumn 6, Issue , 2005, Pages

  Kokkola, Tarja ^a   Savinainen, Juha R ^a   Mönkkönen, Kati S ^a   Retamal, Montse Durán ^a   Laitinen, Jarmo T ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 1 RECEPTOR; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M4 RECEPTOR; PURINE P2Y12 RECEPTOR; S NITROSOCYSTEINE; S NITROSOGLUTATHIONE; S NITROSOTHIOL;

ANIMAL CELL; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BINDING SITE; CELL CULTURE; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR MECHANICS; NITROSYLATION; NONHUMAN; PROTEIN EXPRESSION; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; REGULATORY MECHANISM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 25444442630     PISSN: 14712121     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-6-21     Document Type: Article

References (81)

1. Fredriksson R, Lagerstrom MC, Lundin LG, Schioth HB: The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 2003, 63:1256-1272.
2. Vassilatis DK, Hohmann JG, Zeng H, Li F, Ranchalis JE, Mortrud MT, Brown A, Rodriguez SS, Weller JR, Wright AC, Bergmann JE, Gaitanaris GA: The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci U S A 2003, 100:4903-4908.
3. Wise A, Gearing K, Rees S: Target validation of G-protein coupled receptors. Drug Discov Today 2002, 7:235-246.
4. Pierce KL, Premont RT, Lefkowitz RJ: Seven-transmembrane receptors. Nat Rev Mol Cell Biol 2002, 3:639-650.
5. Neubig RR, Siderovski DP: Regulators of G-protein signalling as new central nervous system drug targets. Nat Rev Drug Discov 2002, 1:187-197.
6. Blumer JB, Lanier SM: Accessory proteins for G protein-signaling systems: activators of G protein signaling and other non-receptor proteins influencing the activation state of G proteins. Receptors Channels 2003, 9:195-204.
7. Davis KL, Martin E, Turko IV, Murad F: Novel effects of nitric oxide. Annu Rev Pharmacol Toxicol 2001, 41:203-236.
8. Liu Z, Rudd MA, Freedman JE, Loscalzo J: S-Transnitrosation reactions are involved in the metabolic fate and biological actions of nitric oxide. J Pharmacol Exp Ther 1998, 284:526-534.
9. Arnelle DR, Stamler JS: NO+, NO, and NO- donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. Arch Biochem Biophys 1995, 318:279-285.
10. Ji Y, Akerboom TP, Sies H, Thomas JA: S-nitrosylation and S-glutathiolation of protein sulfhydryls by S-nitroso glutathione. Arch Biochem Biophys 1999, 362:67-78.
11. Konorev EA, Kalyanaraman B, Hogg N: Modification of creatine kinase by S-nitrosothiols: S-nitrosation vs. S-thiolation. Free Radic Biol Med 2000, 28:1671-1678.
12. Xian M, Chen X, Liu Z, Wang K, Wang PG: Inhibition of papain by S-nitrosothiols. Formation of mixed disulfides. J Biol Chem 2000, 275:20467-20473.
13. Hess DT, Matsumoto A, Nudelman R, Stamler JS: S-nitrosylation: spectrum and specificity. Nat Cell Biol 2001, 3:E46-E49.
14. Stamler JS, Lamas S, Fang FC: Nitrosylation. The prototypic redox-based signaling mechanism. Cell 2001, 106:675-683.
15. Ahern GP, Klyachko VA, Jackson MB: cGMP and S-nitrosylation: two routes for modulation of neuronal excitability by NO. Trends Neurosci 2002, 25:510-517.
16. Hogg N: The biochemistry and physiology of S-nitrosothiols. Annu Rev Pharmacol Toxicol 2002, 42:585-600.
17. Tao L, English AM: Protein S-glutathiolation triggered by decomposed S-nitrosoglutathione. Biochemistry 2004, 43:4028-4038.
18. Lipton SA, Choi YB, Takahashi H, Zhang D, Li W, Godzik A, Bankston LA: Cysteine regulation of protein function - as exemplified by NMDA-receptor modulation. Trends Neurosci 2002, 25:474-480.
19. Foster MW, McMahon TJ, Stamler JS: S-nitrosylation in health and disease. Trends Mol Med 2003, 9:160-168.
20. Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS: Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Bio 2005, 6:150-166.
21. Ehret-Hilberer S, Nullans G, Aunis D, Virmaux N: Mono ADP-ribosylation of transducin catalyzed by rod outer segment extract. FEBS Lett 1992, 309:394-398.
22. Lander HM, Sehajpal PK, Novogrodsky A: Nitric oxide signaling: a possible role for G proteins. J Immunol 1993, 151:7182-7187.
23. Pozdnyakov N, Lloyd A, Reddy VN, Sitaramayya A: Nitric oxide-regulated endogenous ADP-ribosylation of rod outer segment proteins. Biochem Biophys Res Commun 1993, 192:610-615.
24. Hess DT, Lin LH, Freeman JA, Norden JJ: Modification of cysteine residues within G(o) and other neuronal proteins by exposure to nitric oxide. Neuropharmacology 1994, 33:1283-1292.
25. Pozdnyakov N, Margulis A, Sitaramayya A: Endogenous ADP-ribosylation of a G(alpha i) protein in bovine ciliary body is stimulated by nitric oxide. Biochem Biophys Res Commun 1997, 235:482-486.
26. Miyamoto A, Laufs U, Pardo C, Liao JK: Modulation of bradykinin receptor ligand binding affinity and its coupled G-proteins by nitric oxide. J Biol Chem 1997, 272:19601-19608.
27. McVey M, Hill J, Howlett A, Klein C: Adenylyl cyclase, a coincidence detector for nitric oxide. J Biol Chem 1999, 274:18887-18892.
28. Naganuma T, Maekawa M, Murayama T, Nomura Y: Effects of Snitroso-cysteine on proteins that regulate exocytosis in PC12 cells: inhibitory effects on translocation of synaptophysin and ADP-ribosylation of GTP-binding proteins. Jpn J Pharmacol 2000, 84:391-398.
29. Nishida M, Maruyama Y, Tanaka R, Kontani K, Nagao T, Kurose H: G alpha(i) and G alpha(o) are target proteins of reactive oxygen species. Nature 2000, 408:492-495.
30. Hill J, Howlett A, Klein C: Nitric oxide selectively inhibits adenylyl cyclase isoforms 5 and 6. Cell Signal 2000, 12:233-237.
31. Hudson TY, Corbett JA, Howlett AC, Klein C: Nitric oxide regulates adenylyl cyclase activity in rat striatal membranes. J Neurochem 2001, 77:1279-1284.
32. Peters SL, Sand C, Batinik HD, Pfaffendorf M, van Zwieten PA: Reactive oxygen species potentiate the negative inotropic effect of cardiac M2-muscarinic receptor stimulation. Naunyn-Schmiedebergs Arch Pharmacol 2001, 364:166-171.
33. Nishida M, Schey KL, Takagahara S, Kontani K, Katada T, Urano Y, Nagano T, Nagao T, Kurose H: Activation mechanism of Gi and Go by reactive oxygen species. J Biol Chem 2002, 277:9036-9042.
34. Nozik-Grayck E, McMahon TJ, Huang YC, Dieterle CS, Stamler JS, Piantadosi CA: Pulmonary vasoconstriction by serotonin is inhibited by S-nitroso-glutathione. Am J Physiol Lung Cell Mol Physiol 2002, 282:L1057-L1065.
35. Ostrom RS, Bundey RA, Insel PA: Nitric oxide inhibition of adenylyl cyclase type 6 activity is dependent upon lipid rafts and caveolin signaling complexes. J Biol Chem 2004, 279:19846-19853.
36. Laitinen JT: [35S]GTPγS Autoradiography: A powerful functional approach with expanding potential for neuropharmacological studies on receptors coupled to Gi family of G proteins. Current Neuropharmacology 2004, 2:191-206.
37. Ostrom RS, Liu X, Head BP, Gregorian C, Seasholtz TM, Insel PA: Localization of adenylyl cyclase isoforms and G protein-coupled receptors in vascular smooth muscle cells: expression in caveolin-rich and noncaveolin domains. Mol Pharmacol 2002, 62:983-992.
38. Bourova L, Kostrnova A, Hejnova L, Moravcova Z, Moon HE, Novotny J, Milligan G, Svoboda P: delta-Opioid receptors exhibit high efficiency when activating trimeric G proteins in membrane domains. J Neurochem 2003, 85:34-49.
39. Foster LJ, De Hoog CL, Mann M: Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc Natl Acad Sci U S A 2003, 100:5813-5818.
40. Insel P: Location, location, location. Trends Endocrinol Metab 2003, 14:100-102.
41. Laitinen JT, Uri A, Raidaru G, Miettinen R: [35S]GTPγS autoradiography reveals a wide distribution of Gi/o-linked ADP receptors in the nervous system: close similarities with the platelet P2YADP receptor. J Neurochem 2001, 77:505-518.
42. Vasiljev KS, Uri A, Laitinen JT: 2-Alkylthio-substituted platelet P2Y12 receptor antagonists reveal pharmacological identity between the rat brain Gi-linked ADP receptors and P2Y12. Neuropharmacology 2003, 45:145-154.
43. Waeber C, Chiu ML: In vitro autoradiographic visualization of guanosine-5′-O-(3-[35S]thio)triphosphate binding stimulated by sphingosine 1-phosphate and lysophosphatidic acid. J Neurochem 1999, 73:1212-1221.
44. Capece ML, Baghdoyan HA, Lydic R: Carbachol stimulates [35S]guanylyl 5′-(gamma-thio)-triphosphate binding in rapid eye movement sleep-related brainstem nuclei of rat. J Neurosci 1998, 18:3779-3785.
45. Demarco GJ, Baghdoyan HA, Lydic R: Differential cholinergic activation of G proteins in rat and mouse brainstem: relevance for sleep and nociception. J Comp Neurol 2003, 457:175-184.
46. Gaston B, Reilly J, Drazen JM, Fackler J, Ramdev P, Arnelle D, Mullins ME, Sugarbaker DJ, Chee C, Singel DJ: Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci U S A 1993, 90:10957-10961.
47. Kluge I, Gutteck-Amsler U, Zollinger M, Do KQ: S-nitrosoglutathione in rat cerebellum: identification and quantification by liquid chromatography-mass spectrometry. J Neurochem 1997, 69:2599-2607.
48. Jalink K, Hordijk PL, Moolenaar WH: Growth factor-like effects of lysophosphatidic acid, a novel lipid mediator. Biochim Biophys Acta 1994, 1198:185-196.
49. Huber CM, Saffrich R, Ansorge W, Just WW: Receptor-mediated regulation of peroxisomal motility in CHO and endothelial cells. EMBO J 1999, 18:5476-5485.
50. McAllister G, Stanton JA, Salim K, Handford EJ, Beer MS: Edg2 receptor functionality: gialpha1 coexpression and fusion protein studies. Mol Pharmacol 2000, 58:407-412.
51. Ohlmann P, Laugwitz KL, Nurnberg B, Spicher K, Schultz G, Cazenave JP, Gachet C: The human platelet ADP receptor activates Gi2 proteins. Biochem J 1995, 312:775-779.
52. Jantzen HM, Milstone DS, Gousset L, Conley PB, Mortensen RM: Impaired activation of murine platelets lacking G alpha(i2). J Clin Invest 2001, 108:477-483.
53. Lander HM, Hajjar DP, Hempstead BL, Mirza UA, Chait BT, Campbell S, Quilliam LA: A molecular redox switch on p21(ras). Structural basis for the nitric oxide-p21(ras) interaction. J Biol Chem 1997, 272:4323-4326.
54. Selkirk JV, Price GW, Nahorski SR, Challiss RA: Cell type-specific differences in the coupling of recombinant mGlu1alpha receptors to endogenous G protein sub-populations. Neuropharmacology 2001, 40:645-656.
55. Yang J, Wu J, Kowalska MA, Dalvi A, Prevost N, O'Brien PJ, Manning D, Poncz M, Lucki I, Blendy JA, Brass LF: Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs. Proc Natl Acad Sci USA 2000, 97:9984-9989.
56. Fang M, Jaffrey SR, Sawa A, Ye K, Luo X, Snyder SH: Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON. Neuron 2000, 28:183-193.
57. Jaffrey SR, Fang M, Snyder SH: Nitrosopeptide mapping: a novel methodology reveals s-nitrosylation of dexras1 on a single cysteine residue. Chem Biol 2002, 9:1329-1335.
58. Graham TE, Qiao Z, Dorin RI: Dexras1 inhibits adenylyl cyclase. Biochem Biophys Res Commun 2004, 316:307-312.
59. Graham TE, Prossnitz ER, Dorin RI: Dexras1/AGS-1 inhibits signal transduction from the Gi-coupled formyl peptide receptor to Erk-1/2 MAP kinases. J Biol Chem 2002, 277:10876-10882.
60. Takesono A, Nowak MW, Cismowski M, Duzic E, Lanier SM: Activator of G-protein signaling 1 blocks GIRK channel activation by a G-protein-coupled receptor: apparent disruption of receptor signaling complexes. J Biol Chem 2002, 277:13827-13830.
61. Dunphy JT, Greentree WK, Linder ME: Enrichment of G-protein palmitoyltransferase activity in low density membranes: in vitro reconstitution of Galphai to these domains requires palmitoyltransferase activity. J Biol Chem 2001, 276:43300-43304.
62. Wedegaertner PB, Chu DH, Wilson PT, Levis MJ, Bourne HR: Palmitoylation is required for signaling functions and membrane attachment of Gq alpha and Gs alpha. J Biol Chem 1993, 268:25001-25008.
63. Sprang SR: G proteins, effectors and GAPs: structure and mechanism. Curr Opin Struct Biol 1997, 7:849-856.
64. Adam L, Bouvier M, Jones TL: Nitric oxide modulates beta(2)-adrenergic receptor palmitoylation and signaling. J Biol Chem 1999, 274:26337-26343.
65. Han X, Kubota I, Feron O, Opel DJ, Arstall MA, Zhao YY, Huang P, Fishman MC, Michel T, Kelly RA: Muscarinic cholinergic regulation of cardiac myocyte ICa-L is absent in mice with targeted disruption of endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 1998, 95:6510-6515.
66. Dessy C, Kelly RA, Balligand JL, Feron O: Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling. EMBO J 2000, 19:4272-4280.
67. Maggio R, Barbier P, Toso A, Barletta D, Corsini GU: Sodium nitroprusside induces internalization of muscarinic receptors stably expressed in Chinese hamster ovary cell lines. J Neurochem 1995, 65:943-946.
68. Abi-Gerges N, Szabo G, Otero AS, Fischmeister R, Mery PF: NO donors potentiate the beta-adrenergic stimulation of I(Ca,L) and the muscarinic activation of I(K,ACh) in rat cardiac myocytes. J Physiol 2002, 540:411-424.
69. Dorsam RT, Kunapuli SP: Central role of the P2Y12 receptor in platelet activation. J Clin Invest 2004, 113:340-345.
70. Tullett JM, Rees DD, Shuker DE, Gescher A: Lack of correlation between the observed stability and pharmacological properties of S-nitroso derivatives of glutathione and cysteine-related peptides. Biochem Pharmacol 2001, 62:1239-1247.
71. Radomski MW, Rees DD, Dutra A, Moncada S: S-nitroso-glutathione inhibits platelet activation in vitro and in vivo. Br J Pharmacol 1992, 107:745-749.
72. Gordge M P, Hothersall JS, Noronha-Dutra AA: Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione. Br J Pharmacol 1998, 124:141-148.
73. Freedman JE, Sauter R, Battinelli EM, Ault K, Knowles C, Huang PL, Loscalzo J: Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene. Circ Res 1999, 84:1416-1421.
74. Aktas B, Honig-Liedl P, Walter U, Geiger J: Inhibition of platelet P2Y12 and alpha2A receptor signaling by cGMP-dependent protein kinase. Biochem Pharmacol 2002, 64:433-439.
75. Kou R, Igarashi J, Michel T: Lysophosphatidic acid and receptor-mediated activation of endothelial nitric-oxide synthase. Biochemistry 2002, 41:4982-4988.
76. Karliner JS: Lysophospholipids and the cardiovascular system. Biochim Biophys Acta 2002, 1582:216-221.
77. Siess W: Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate. Biochim Biophys Acta 2002, 1582:204-215.
78. Kokkola T, Foord SM, Watson MA, Vakkuri O, Laitinen JT: Important amino acids for the function of the human MT1 melatonin receptor. Biochem Pharmacol 2003, 65:1463-1471.
79. Laitinen JT: Selective detection of adenosine A1 receptor-dependent G-protein activity in basal and stimulated conditions of rat brain [35S]guanosine 5′-(gamma-thio)triphosphate autoradiography. Neuroscience 1999, 90:1265-1279.
80. Kurkinen KM, Koistinaho J, Laitinen JT: Gamma-35S]GTP autoradiography allows region-specific detection of muscarinic receptor-dependent G-protein activation in the chick optic tectum. Brain Res 1997, 769:21-28.
81. Savinainen JR, Järvinen T, Laine K, Laitinen JT: Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes. Br J Pharmacol 2001, 134:664-672.